Clinicopathologic study of large cell anaplastic lymphoma (Ki-1-positive large cell lymphoma) among the Japanese

Cancer. 1991 Jul 1;68(1):118-29. doi: 10.1002/1097-0142(19910701)68:1<118::aid-cncr2820680123>3.0.co;2-r.

Abstract

The clinical, prognostic, phenotypic, and genotypic findings of 30 patients with large cell anaplastic lymphoma (Ki-1-positive large cell lymphoma) were analyzed. There were 13 male and 17 female patients (male-female ratio, 0.8) whose ages ranged from 3 to 81 years of age (mean, 28 years of age; 67% of the patients younger than 30 years of age). The 5-year survival rate was 52%; this was better than that of other types of high-grade peripheral T-cell lymphoma. Histologic examination showed distinctive morphologic features such as tumor cell pleomorphism, sinus infiltration, fibrosis, partial lymph node involvement, sparing of B-cell regions, and occasional plasma cell infiltrates. Eighty percent of the cases were of T-cell phenotype, and others expressed neither B-cell nor T-cell markers. The tumors were frequently positive for a histocompatibility antigen (HLA-DR), CD25 (the interleukin-2 receptor), and epithelial membrane antigen. Rearrangements of the T-cell receptor beta gene were observed in nine of 13 cases (69%). These findings indicated that many of the tumors had the phenotype and genotype of activated T-cells. This study also showed that large cell anaplastic lymphoma has a survival figure intermediate between Hodgkin's disease and low-grade peripheral T-cell lymphoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal
  • Antigens, CD / analysis
  • B-Lymphocytes / pathology
  • Blotting, Southern
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Cytoplasm / ultrastructure
  • Female
  • HLA-DR Antigens / analysis
  • Hodgkin Disease / mortality
  • Humans
  • Immunoenzyme Techniques
  • Japan
  • Lymphoma, Large B-Cell, Diffuse / ethnology*
  • Lymphoma, Large B-Cell, Diffuse / mortality
  • Lymphoma, Large B-Cell, Diffuse / pathology*
  • Lymphoma, Large B-Cell, Diffuse / therapy
  • Male
  • Middle Aged
  • Organelles / ultrastructure
  • Phenotype
  • Prognosis
  • Survival Rate
  • T-Lymphocytes / pathology

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • HLA-DR Antigens